SAVA stock is volatile but worthwhile as its Alzheimer's drug inches closer to commercialization. Risk tolerance is needed, but likely smart More
Articles
Ripple Remains Speculative Until Big Investors Get Aboard XRP-USD
XRP-USD has not achieved the disruption Ripple investors have been waiting for. Financial institutions will be reluctant to use the token until the Ripple-SEC legal fray ends. More
Upstart Stock Is Wildly Overvalued and Set to Crash
UPST stock is trading at a preposterous valuation given the company's unproven business model in a fiercely competitive market. More
ContextLogic Stock Dips Deceive Investors as Shares Remain Expensive
ContextLogic lost 28% of its value in the past month. While WISH stock trades near $5, well off its February 52-week high, do not buy on the dips. More
Amazon Stock Just Needs a Little Christmas to Brighten Investor Faces
Amazon is no longer the scrappy underdog, but the hulking giant of American business. The negative press coverage has halted AMZN stock's rise, even while the business keeps growing. More
AMC Stock Will Bomb at the Stock Market Even as Headwinds Are Fading
Attendance has improved for AMC stock but achieving pre-pandemic levels for the foreseeable future seems unlikely. More
How to Hit Financial Escape Velocity
What turns an 89% gain into a 1,506% monster … a strategy to help you reach financial freedom … where Eric and Louis are looking in today’s market for “escape velocity” trades In early 2020, our macro specialist, Eric Fry, saw an opportunity in copper. To play it, he recommended Freeport McMoRan (FCX), one… More
